IgG subclass antibodies to glutamic acid decarboxylase and risk for progression to clinical insulin-dependent diabetes

Human Immunology

Volumn 59, Issue 8, 1998, Pages 493-499

  Couper, Jennifer J ^a   Harrison, Leonard C ^b   Aldis, Jacqueline J E ^b   Colman, Peter G ^b   Honeyman, Margo C ^b   Ferrante, Antonio ^b  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GLUTAMATE DECARBOXYLASE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; INSULIN ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; PANCREAS ISLET CELL ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HELPER CELL; HLA TYPING; HUMAN; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; RISK ASSESSMENT;

ADOLESCENT; ADULT; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUTAMATE DECARBOXYLASE; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOGLOBULIN G; INSULIN; ISLETS OF LANGERHANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0031904314     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(98)00040-8     Document Type: Article

References (28)

1. Powrie F, Coffman RL: Cytokine regulation of T cell function: potential for therapeutic intervention. Immunol Today 14:270-274, 1993.
2. H2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145-173, 1989.
3. Fitch FW, McKisic MD, Lancki DW, Gajewski TF: Differential regulation of murine T lymphocyte subsets. Annu Rev Immunol 11:29-48, 1993.
4. H2 subsets: regulation of differentiation and role in protection and immunopathology. Int Arch Allergy Immunol 98:279-285, 1992.
5. Rothman P, Lutzker S, Cook W, Coffman R, Alt FW: Mitogen plus interleukin 4 induction of Ce transcripts in B lymphoid cells. J Exp Med 168:2385-2389, 1988.
6. Snapper CM, Paul WE: Interferon-g and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236:944-947, 1987.
7. Baekkeskov S, Aanstoot S, Christgau A, Reetz A, Solimena A, Cascalho M, Folli F, Richter-Olesen H, De Camilli P: Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347:151-156, 1990.
8. Harrison LC: Islet cell autoantigens in insulin-dependent diabetes: Pandora's box revisited. Immunol Today 13: 348-352, 1992.
9. Kaufman DL, Clare-Salzler M, Tian J et al: Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366:69-72, 1993.
10. Tisch R, Yang X-D, Singer SM, Liblas RS, Fugger L, McDevitt HO: Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366:72-75, 1993.
11. DeAizpurua HJ, French MB, Chosich N, Harrison LC: Natural history of humoral immunity to glutamic acid decarboxylase in non-obese diabetic (NOD) mice. J Autoimmunity 7:643-653, 1994.
12. Harrison LC, Honeyman MC, DeAizpurua HJ, Schmidli RS, Tait BD, Cram DS Colman PG: Inverse relationship between humoral and cellular immunity to glutamic acid decarboxylase in humans at-risk for insulin-dependent diabetes. Lancet 341:1365-1369, 1993.
13. Lundgren M, Persson U, Lansson P, Magnusson C, Smith CIE, Hammarstrom L, Severinson E: Interleukin 4 induces synthesis of IgE and IgG4 in human B cells. Eur J Immunol 19:1311-1315, 1989.
14. Snapper CM, Mond JJ: Towards a comprehensive view of immunoglobulin class switching. Immunol Today 14:15-17, 1995.
15. Ferrante A, Beard LJ, Roberton DM: Review: IgG subclass deficiency. Pediatr Allergy Immunol 2:49-62, 1991.
16. DeAizpurua HJ, Wilson Y, Harrison LC: Glutamic acid decarboxylase (GAD) autoantibodies in pre-clinical insulin-dependent diabetes. Proc Natl Acad Sci USA 89: 9841-9845, 1992.
17. Schmidli RS, Colman PG, Bonifacio E, Bottazzo GF, Harrison LC and participating institutions: High level of concordance between assays for glutamic acid decarboxyl-ase antibodies (GAD Ab): The First International GAD Ab Workshop. Diabetes 43:1005-1009, 1994.
18. Ferrante A, Beard LJ, Feldman RG: IgG subclass distribution of antibodies to bacterial and viral antigens. Paed Infect Dis J 9 (8):S16-S24, 1990.
19. Pilcher C, Elliott RB: A sensitive and reproducible method for the assay of human islet cell antibodies. J Immunol Meth 129:111-117, 1990.
20. Harrop M, Caudwell JP, Stojanovski C, Colman PG: Insulin autoantibodies in patients with autoimmune diseases. Diabetes Res Clin Pract 18:107-112, 1992.
21. Dean BM, Bottazzo GF, Cudworth AG: IgG subclass distribution in organ-specific autoantibodies. The relationship to complement fixing ability. Clin Exp Immunol 52:61-66, 1983.
22. Bruining GJ, Molenaar J, Tuk CW, Lideman J, Bruining HA, Marrer B: Clinical time course and characteristics of islet cell cytoplasmic antibodies in childhood diabetes. Diabetologia 26:24-29, 1984.
23. Millward A, Hussain MJ, Peakman M, Pyke DA, Leslie RDG, Vergani D: Characterization of islet cell antibody in insulin-dependent diabetes: evidence for IgG1 subclass restriction and polyclonality. Clin Exp Immunol 71:353-356, 1988.
24. Schatz DA, Barrett DJ, Maclaren N, Riley WJ: Polyclonal nature of islet cell antibodies in insulin-dependent diabetes. Autoimmunity 1:45-50, 1988.
25. Dozio N, Belloni C, Girardi AM, Genovese S, Sodoyez JC, Bottazzo GF, Pozza G, Bosi E: Heterogeneous IgG subclass distribution of islet cell antibodies. J Autoimmunity 7:45-53, 1994.
26. Honeyman MC, Harrison LC, Drummond B, Colman PG, Tait BD: Analysis of families at risk for insulin-dependent diabetes reveals that HLA antigens influence progression to preclinical disease. Mol Med 1:576-582, 1995.
27. Parish C: The relationship between humoral and cell-mediated immunity. Transplant Rev 13:35-66, 1972.
28. Gianani R, Pugliese A, Bonner-Weir S, Shiffrin AJ, Soelober JS, Erlich H: Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type 1 diabetes. Diabetes 41:347-353, 1992.